Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Liabilities and Shareholders Equity (2016 - 2017)

Bone Biologics (BBLG) has disclosed Liabilities and Shareholders Equity for 2 consecutive years, with $1.7 million as the latest value for Q3 2017.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 116.3% to $1.7 million in Q3 2017 year-over-year; TTM through Dec 2017 was $4.2 million, a 47.92% decrease, with the full-year FY2016 number at $701140.0, changed N/A from a year prior.
  • Liabilities and Shareholders Equity was $1.7 million for Q3 2017 at Bone Biologics, up from $868389.0 in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $4.3 million in Q1 2016 to a low of $701140.0 in Q4 2016.